Evidence map›Paper›PMID 31664519›Full record

ArticleEuropean journal of nutrition2020

Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model.

Karthika Muthuramalingam, Vineet Singh, Changmin Choi, Seung In Choi, Young Mee Kim, Tatsuya Unno, Moonjae Cho

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Karthika MuthuramalingamDepartment of Biochemistry, School of Medicine, Jeju National University, Jeju, 63243, Republic of Korea.
Vineet SinghFaculty of Biotechnology, School of Life Sciences, SARI, Jeju National University, Jeju, 63243, Republic of Korea.
Changmin ChoiDepartment of Biochemistry, School of Medicine, Jeju National University, Jeju, 63243, Republic of Korea.
Seung In ChoiDepartment of Pharmaceutical Research Institute, Quegen Biotech Co. Ltd, Seoul, 429931, Republic of Korea.
Young Mee KimDepartment of Biochemistry, School of Medicine, Jeju National University, Jeju, 63243, Republic of Korea.
Tatsuya UnnoFaculty of Biotechnology, School of Life Sciences, SARI, Jeju National University, Jeju, 63243, Republic of Korea. tatsu@jejunu.ac.kr.
Moonjae ChoDepartment of Biochemistry, School of Medicine, Jeju National University, Jeju, 63243, Republic of Korea. moonjcho@jejunu.ac.kr.ORCID http://orcid.org/0000-0003-4799-7584
Jeju National University · KR

Funding

Ministry of Education 2016R1A6A1A03012862Rural Development Administration, Republic of Korea Project No. PJ01331801
6 · The paper itself

Abstract

purposeWestern diet, rich in carbohydrates and fat, is said to be a major factor underlying metabolic syndrome. Interventions with prebiotics, the key modulators of the gut microbiota, have paramount impact on host-associated metabolic disorders. Herein, we investigated the effect of fungus-derived (1,3)/(1,6)-β-glucan, a highly soluble dietary fiber, on high-fat diet (HFD)-induced metabolic distress.

methodsMale C57BL/6 J mice were fed with different diet groups (n = 11): control diet, HFD, 3 g/kg or 5 g/kg of β-glucan-incorporated HFD. At the end of experimental study period (12th week), body weight, feces weight and fecal moisture content were observed. Further, colonic motility was measured using activated charcoal meal study. Proteins extracted from liver and intestine tissues were subjected to western blot technique. Paraffin-embedded intestinal tissues were sectioned for histochemical [Periodic acid-Schiff (PAS) and Alcian blue (AB) staining] analysis. Fecal microbiota analysis was performed using MOTHUR bioinformatic software.

resultsβ-glucan consumption exhibited anti-obesity property in mice groups fed with HFD. In addition, β-glucan ameliorated HFD-induced hepatic stress, colonic motility and intestinal atrophy (reduction in colon length, goblet cells, and mucosal layer thickness). Further, β-glucan incorporation shifted bacterial community by increasing butyrate-producing bacteria such as Anaerostipes, Coprobacillus, and Roseburia and decreasing reportedly obesity-associated bacteria such as Parabacteroides and Lactococcus.

conclusionAltogether, the outcomes of this present pre-clinical animal study show β-glucan to be a promising therapeutic candidate in the treatment of HFD-induced metabolic distress. Further comprehensive research has to be conducted to brace its clinical relevance, reproducibility and efficacy for aiding human health.

Indexed as

beta-GlucansGastrointestinal MicrobiomeAnimalsDiet, High-FatFungiMaleMiceMice, Inbred C57BLPrebioticsReproducibility of Resultsbeta-GlucansPrebioticsGut microbiotaHigh-fat dietMetabolic syndromeObesityPrebioticsβ-glucan

Identifiers

PMID31664519
OpenAlexW4242922588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.